Sonoma Pharmaceuticals (SNOA) Shares Outstanding (2010 - 2026)

Sonoma Pharmaceuticals' Shares Outstanding (Entity) history runs 13 years deep, the most recent figure standing at $155.0 for Q4 2022.

• On a quarterly basis, Shares Outstanding (Entity) rose 0.65% year-over-year to $155.0 in Q4 2022; TTM through Dec 2022 was $155.0, a 0.65% increase from a year earlier, with the FY2022 full-year figure at $155047.0, up 48.16% from the prior year.
• Shares Outstanding (Entity) was little changed at $155.0 in Q4 2022 per SNOA's latest filing, from $155.0 in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $155047.0 in Q1 2022 and bottomed at $154.0 in Q4 2021.
• The 5-year median for Shares Outstanding (Entity) is $69875.0 (2019), against an average of $71377.6.
• Across the five-year window, Shares Outstanding (Entity) jumped 88.44% in 2018 and plunged 99.87% in 2022, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $48550.0 in 2018, then jumped by 83.06% to $88874.0 in 2019, then rose by 16.97% to $103953.0 in 2020, then slumped by 99.85% to $154.0 in 2021, then climbed by 0.65% to $155.0 in 2022.
• Per Business Quant, the three latest SNOA Shares Outstanding (Entity) figures stand at $155.0 (Q4 2022), $155.0 (Q3 2022), and $155047.0 (Q2 2022).